Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for treatment of major depression
IRCT201208159585N2Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Kerman University of Medical Sciences
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine in major depressive disorder (MDD), sponsored by Vice Chancellor for Research, Kerman University of Medical Sciences. Started Sep 2012; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201208159585N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201208159585N2.